肝再生增强因子通过促进自噬减轻对乙酰氨基酚诱导的小鼠急性肝损伤
该研究在雌性BALB/c小鼠中评估ALR对对乙酰氨基酚(APAP)肝毒性的保护作用及机制。腹腔注射600 mg/kg APAP后3至72小时,血清ALT、AST升高,肝内出血和坏死增加;损伤早期(12小时前)ALR水平显著升高,24小时降至对照水平。ALR治疗增加自噬体、促进LC3 I向LC3 II转化及p62降解,并减轻APAP引起的ALT、AST、MPO、MDA、ROS升高、肝内出血、坏死及SOD和GSH耗竭,抑制线粒体膜间隙蛋白AIF和细胞色素c释放,减少cleaved-caspase 3表达和凋亡细胞。用3-MA抑制自噬可逆转ALR的保护作用,提示ALR通过激活自噬通路发挥保护作用。
要点
- 雌性BALB/c小鼠腹腔注射600 mg/kg APAP后3、6、12、24、48、72小时出现血清ALT、AST升高及肝内出血、坏死。
- APAP损伤早期(12小时前)肝内ALR水平显著升高,24小时降至对照水平。
- ALR治疗增加自噬体、促进LC3 I向LC3 II转化和p62降解,直接诱导自噬流。
- ALR减轻APAP引起的ALT、AST、MPO、MDA、ROS升高、肝内出血、坏死及SOD、GSH耗竭。
- 自噬抑制剂3-MA逆转ALR对APAP肝毒性的保护作用,提示ALR通过激活自噬通路起效。
适用人群与场景
- 雌性BALB/c小鼠,腹腔注射600 mg/kg APAP诱导急性肝损伤模型。
处置流程与药物剂量
- APAP以600 mg/kg腹腔注射建立急性肝损伤模型。
- ALR治疗增加自噬体、促进LC3 I向LC3 II转化及p62降解。
- 3-甲基腺嘌呤(3-MA)用于抑制自噬,可逆转ALR的保护作用。
研究设计与关键结果
- 雌性BALB/c小鼠腹腔注射600 mg/kg APAP后3、6、12、24、48、72小时,血清ALT、AST水平、肝内出血和坏死均增加。
- APAP损伤早期(12小时前)ALR水平显著升高,24小时降至对照水平。
- ALR治疗增加自噬体、促进LC3 I向LC3 II转化及p62降解,并减轻APAP引起的ALT、AST、MPO、MDA、ROS升高、肝内出血、坏死及SOD、GSH耗竭。
- APAP引起线粒体膜间隙蛋白AIF和细胞色素c释放,ALR抑制该变化,并减少cleaved-caspase 3表达和凋亡细胞。
- 3-MA抑制自噬可逆转ALR对APAP肝毒性的有益作用。
证据类型、等级与局限
- 证据类型:动物实验(雌性BALB/c小鼠)。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文为小鼠实验,作者认为ALR通过激活自噬通路保护APAP肝毒性,未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Most cases of acute liver failure are caused by acetaminophen (APAP) overdose. Oxidative stress is a key factor in APAP toxicity. Although augmenter of liver regeneration (ALR) has both antioxidative and antiapoptotic effects, its therapeutic potential in APAP hepatotoxicity remains unknown. The current study assessed the protective effects and associated mechanisms of ALR against APAP-induced acute liver injury in female BALB/c mice. We found that serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, intrahepatic hemorrhage and necrosis were increased at 3, 6, 12, 24, 48, and 72 h after 600 mg/kg APAP i.p. injection. During the early stages (before 12 h) of acute liver injury, ALR levels increased significantly, followed by a decrease to control level at 24 h after APAP administration. ALR treatment increased autophagosomes, promoted the conversion of LC3 I to LC3 II, and the degradation of p62. ALR attenuated APAP-stimulated increases in ALT, AST, myeloperoxidase (MPO), malondialdehyde (MDA), and reactive oxidative species (ROS) levels; intrahepatic hemorrhage; and necrosis as well as superoxide dismutase (SOD) and Glutathione (GSH) depletion. We found that APAP caused release of the mitochondrial intermembrane proteins apoptosis-inducing factor (AIF) and cytochrome c and that ALR inhibited this change. Meanwhile, ALR decreased expression of cleaved-caspase 3 and apoptotic cells. Subsequently, we investigated the significance of autophagy in APAP-induced acute liver injury by treatment with 3-methyladenine (3-MA), which were classical pharmaceuticals for suppressing autophagy. ALR directly induced autophagy flux; and the inhibition of autophagy reversed the beneficial effects of ALR on hepatotoxicity. Our findings suggest that ALR protects against APAP hepatotoxicity by activating the autophagy pathway.
参考来源
- Hu T, Sun H, Deng WY, et al. Augmenter of Liver Regeneration Protects Against Acetaminophen-Induced Acute Liver Injury in Mice by Promoting Autophagy. Shock. 2019. PMID: 30138299. doi:10.1097/SHK.0000000000001250
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。